Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
PLoS One ; 17(1): e0260535, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35100268

RESUMEN

Rice production is affected by many biotic and abiotic stresses; among them, bacterial blight (BB) and blast diseases and low soil phosphorous stress cause significant yield losses. The present study was carried out with the objective of combining the BB resistance gene, Xa21, the blast resistance gene, Pi54, and the low soil phosphorous tolerance QTL/gene, Pup1, into the genetic background of the Indian mega-rice variety, MTU1010 (Cottondora Sannalu), through marker-assisted pedigree breeding. RP5973-20-9-8-24-12-7 [a near isogenic line (NIL) of MTU1010 possessing Pup1] and RP6132 [a NIL of Akshayadhan possessing Xa21 + Pi54] were crossed and 'true' F1s were identified, using the target gene-specific markers and selfed. F2 plants, which are homozygous for all the three target genes/QTLs, were identified using PCR based markers and were advanced further through the pedigree method of breeding, with selection based on phenotypic traits specific for MTU1010. At the F5 generation, a set of 15 promising triple positive homozygous lines were identified and screened for their resistance against BB and blast diseases and tolerance to low soil P. Among them, two lines (LPK 30-18-16 and LPK 49-15-22) showed higher yields as compared to MTU1010, along with the desirable long slender grain type in both low soil P and normal soil P plots, and also exhibited high levels of resistance against BB and blast diseases, with lesser grain shattering as compared to MTU1010. These lines are being advanced for multi-location trials for validating their performance.


Asunto(s)
Resistencia a la Enfermedad/genética , Oryza/genética , Fósforo/análisis , Enfermedades de las Plantas/genética , Suelo/química , Estrés Fisiológico , Bacterias/aislamiento & purificación , Marcadores Genéticos , Genotipo , India , Proteínas de Transporte de Nucleobases/genética , Oryza/crecimiento & desarrollo , Fenotipo , Fitomejoramiento , Enfermedades de las Plantas/microbiología , Proteínas de Plantas/genética , Proteínas Serina-Treonina Quinasas/genética , Sitios de Carácter Cuantitativo
2.
Antimicrob Agents Chemother ; 60(1): 662-5, 2016 01.
Artículo en Inglés | MEDLINE | ID: mdl-26525799

RESUMEN

Treatment of Candida glabrata cystitis remains a therapeutic challenge, and an antifungal combination using flucytosine is one option. We describe two patients with refractory C. glabrata cystitis who failed flucytosine combined with caspofungin with early-acquired high-level resistance to flucytosine due to nonsense mutations in the FUR1 gene. Rapidly acquired flucytosine resistance with microbiological failure should discourage combination of caspofungin and flucytosine during urinary candidiasis.


Asunto(s)
Antifúngicos/administración & dosificación , Candida glabrata/efectos de los fármacos , Candidiasis/tratamiento farmacológico , Cistitis/tratamiento farmacológico , Farmacorresistencia Fúngica/efectos de los fármacos , Equinocandinas/administración & dosificación , Flucitosina/administración & dosificación , Lipopéptidos/administración & dosificación , Anciano , Secuencia de Bases , Candida glabrata/genética , Candida glabrata/aislamiento & purificación , Candida glabrata/metabolismo , Candidiasis/microbiología , Candidiasis/patología , Caspofungina , Codón sin Sentido , Cistitis/microbiología , Cistitis/patología , Farmacorresistencia Fúngica/genética , Quimioterapia Combinada , Femenino , Proteínas Fúngicas/genética , Proteínas Fúngicas/metabolismo , Expresión Génica , Humanos , Masculino , Datos de Secuencia Molecular , Proteínas de Transporte de Nucleobases/genética , Proteínas de Transporte de Nucleobases/metabolismo , Insuficiencia del Tratamiento , Vejiga Urinaria/microbiología , Vejiga Urinaria/patología
3.
Antimicrob Agents Chemother ; 58(8): 4476-85, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-24867971

RESUMEN

We characterized two additional membrane transporters (Fur4p and Dal4p) of the nucleobase cation symporter 1 (NCS1) family involved in the uptake transport of pyrimidines and related molecules in the opportunistic pathogenic yeast Candida lusitaniae. Simple and multiple null mutants were constructed by gene deletion and genetic crosses. The function of each transporter was characterized by supplementation experiments, and the kinetic parameters of the uptake transport of uracil were measured using radiolabeled substrate. Fur4p specifically transports uracil and 5-fluorouracil. Dal4p is very close to Fur4p and transports allantoin (glyoxyldiureide). Deletion of the FUR4 gene confers resistance to 5-fluorouracil as well as cross-resistance to triazoles and imidazole antifungals when they are used simultaneously with 5-fluorouracil. However, the nucleobase transporters are not involved in azole uptake. Only fluorinated pyrimidines, not pyrimidines themselves, are able to promote cross-resistance to azoles by both the salvage and the de novo pathway of pyrimidine synthesis. A reinterpretation of the data previously obtained led us to show that subinhibitory doses of 5-fluorocytosine, 5-fluorouracil, and 5-fluorouridine also were able to trigger resistance to fluconazole in susceptible wild-type strains of C. lusitaniae and of different Candida species. Our results suggest that intracellular fluorinated nucleotides play a key role in azole resistance, either by preventing azoles from targeting the lanosterol 14-alpha-demethylase or its catalytic site or by acting as a molecular switch for the triggering of efflux transport.


Asunto(s)
Antifúngicos/farmacología , Candida/efectos de los fármacos , Proteínas Fúngicas/genética , Eliminación de Gen , Regulación Fúngica de la Expresión Génica , Proteínas de Transporte de Nucleobases/genética , Proteínas de Transporte de Nucleótidos/genética , Azoles/farmacología , Transporte Biológico , Candida/genética , Candida/metabolismo , Cruzamientos Genéticos , Antagonismo de Drogas , Farmacorresistencia Fúngica , Flucitosina/farmacología , Fluorouracilo/farmacología , Proteínas Fúngicas/metabolismo , Pruebas de Sensibilidad Microbiana , Proteínas de Transporte de Nucleobases/metabolismo , Proteínas de Transporte de Nucleótidos/metabolismo , Esterol 14-Desmetilasa/genética , Esterol 14-Desmetilasa/metabolismo , Uracilo/farmacología , Uridina/análogos & derivados , Uridina/farmacología
4.
Nucleic Acids Res ; 41(10): e106, 2013 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-23525464

RESUMEN

Riboswitches are mRNA elements that specifically bind cellular metabolites and control gene expression by modifying their structure. As riboswitches often control essential genes in pathogenic bacteria, riboswitches have been proposed as new targets for antibiotics. High-throughput screening provides a powerful approach to identify riboswitch ligand analogs that could act as powerful antibacterial drugs. Biochemical assays have already been used to find riboswitch-binding analogs, but those methods do take into account the transcriptional context for riboswitch regulation. As the importance of co-transcriptional ligand binding has been shown for several riboswitches, it is vital to develop an assay that screens riboswitch-binding analogs during the transcriptional process. Here, we describe the development of a dual molecular beacon system monitoring the transcriptional regulation activity of the Bacillus subtilis pbuE adenine riboswitch. This system relies on two molecular beacons that enable the monitoring of transcription efficiency, as well as the regulatory activity of the riboswitch. Different analogs were tested using our system, and a good correlation was observed between riboswitch activity and reported metabolite affinities. This method is specific, reliable and could be applied at the high-throughput level for the identification of new potential antibiotics targeting any riboswitch-regulating gene expression at the mRNA level.


Asunto(s)
Colorantes Fluorescentes/química , Regulación de la Expresión Génica/efectos de los fármacos , Sondas de Ácido Nucleico/química , Riboswitch/efectos de los fármacos , Transcripción Genética/efectos de los fármacos , Adenina/análogos & derivados , Adenina/farmacología , Bacillus subtilis/genética , Evaluación Preclínica de Medicamentos , Guanina/análogos & derivados , Guanina/farmacología , Ligandos , Proteínas de Transporte de Nucleobases/genética , Espectrometría de Fluorescencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA